Spastin Antikörper (AA 551-616) (Cy3)
(1 reference)-
- Target Alle Spastin (SPAST) Antikörper anzeigen
- Spastin (SPAST)
-
Bindungsspezifität
- AA 551-616
-
Reaktivität
- Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Spastin Antikörper ist konjugiert mit Cy3
-
Applikation
- Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Kreuzreaktivität
- Maus, Ratte
- Homologie
- Human,Dog,Cow,Pig,Horse,Chicken,Rabbit
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human FSP
- Isotyp
- IgG
- Top Product
- Discover our top product SPAST Primärantikörper
-
anti-Spastin (SPAST) (AA 200-304) antibody
SPAST Reaktivität: Human WB, ELISA, IF, IHC (p) Wirt: Maus Monoclonal 2F5 unconjugated
anti-Spastin (SPAST) (AA 551-616) antibodySPAST Reaktivität: Maus, Ratte WB, ELISA, FACS, IF (cc), IF (p), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Spastin (SPAST) antibodySPAST Reaktivität: Maus, Human, Ratte ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Spastin (SPAST) (AA 200-304) antibodySPAST Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3A12 unconjugated
anti-Spastin (SPAST) antibodySPAST Reaktivität: Maus, Human, Ratte WB, ELISA, IHC, IF, Coat, StM Wirt: Maus Monoclonal Sp 3G11-1 unconjugated
-
- Applikationshinweise
-
FCM 1:20-100
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
-
: "Piezoelectric PU/PVDF electrospun scaffolds for wound healing applications." in: Colloids and surfaces. B, Biointerfaces, Vol. 96, pp. 29-36, (2012) (PubMed).
-
: "Piezoelectric PU/PVDF electrospun scaffolds for wound healing applications." in: Colloids and surfaces. B, Biointerfaces, Vol. 96, pp. 29-36, (2012) (PubMed).
-
- Target
- Spastin (SPAST)
- Abstract
- SPAST Produkte
- Synonyme
- CG5977 antikoerper, D-spastin antikoerper, Dmel\\CG5977 antikoerper, Dspastin antikoerper, Spas antikoerper, zgc:85952 antikoerper, SPAST antikoerper, spg4 antikoerper, LOC100224472 antikoerper, ADPSP antikoerper, FSP2 antikoerper, SPG4 antikoerper, Spg4 antikoerper, mKIAA1083 antikoerper, spastin antikoerper, spastin S homeolog antikoerper, spas antikoerper, spast antikoerper, SPAST antikoerper, Spast antikoerper, spast.S antikoerper
- Hintergrund
-
Synonyms: FSP2, SPG4, ADPSP, Spastin, Spastic paraplegia 4 protein, SPAST, KIAA183
Background: ATP-dependent microtubule severing protein. Microtubule severing may promote reorganization of cellular microtubule arrays and the release of microtubules from the centrosome following nucleation. Required for membrane traffic from the endoplasmic reticulum (ER) to the Golgi and for completion of the abscission stage of cytokinesis. May also play a role in axon growth and the formation of axonal branches.
- Gen-ID
- 6683
- UniProt
- Q9UBP0
- Pathways
- Microtubule Dynamics, M Phase, Regulation of Cell Size
-
